Table 1.
Vehicle | LT | LT lethal | ||
---|---|---|---|---|
Body weight (g) | 25.4 ± 0.5 | 26.1 ± 0.8 | 25.3 ± 0.8 | |
Serum albumin (g/l) | 18.9 ± 1.3 | 16.9 ± 1.2 | 11.3 ± 2.1* | |
Blood pressure | Systolic (mmHg) | 121.5 ± 6.8 | 122.6 ± 4.7 | n.a. |
Diastolic (mmHg) | 81.3 ± 7.0 | 81.8 ± 3.9 | n.a. | |
Heart rate (bpm) | 733 ± 36 | 740 ± 29 | n.a. | |
Blood count | Lymphocyte (%) | 85 ± 5.6 | 88.2 ± 3.2 | 53 ± 5.7* |
Neutrophil (%) | 8.2 ± 3.8 | 6.8 ± 0.8 | 15.5 ± 0.7* | |
Monocyte (%) | 3.4 ± 1.7 | 3.2 ± 1.6 | 31.5 ± 6.4* | |
Eosinophil (%) | 1.6 ± 1.1 | 0.6 ± 0.9 | 0 ± 0 | |
Basophil (%) | 1.8 ± 1.3 | 1.2 ± 1.3 | 0.5 ± 0.7 | |
Wet/Dry ratio | Lung | 4.2 ± 0.3 | 4.2 ± 0.24 | 4.48 ± 0.1* |
Heart | 4.08 ± 0.13 | 4.06 ± 0.36 | 4.42 ± 0.18* | |
Echocardiography | LVEDV (μl) | 43.7 ± 6.9 | 43.7 ± 3.1 | n.a. |
SV (μl) | 35.4 ± 2.1 | 38.9 ± 2.1 | n.a. | |
LVM (mg) | 133.2 ± 30.7 | 142.3 ± 26.3 | n.a. | |
EF (%) | 82.3 ± 11.6 | 82.5 ± 13.7 | n.a. | |
Endothelial function | LogIC50 (M Carbachol) | −5.2 ± 0.33 | −5.25 ± 0.14 | n.a. |
LogIC50 (M Nitro) | −5.36 ± 0.38 | −5.43 ± 0.51 | n.a. |
Wild-type mice were treated for 4 weeks with vehicle or LT in the therapeutic dose of 0.1 μg LT/week via osmotic mini-pumps or received a lethal dose of LT (150 ng/kg i.p.), and body weight, heart rate, blood pressure, endothelial function, echocardiographic parameters, differential blood count and markers of vascular permeability were evaluated. LVEDV, left ventricular end-diastolic volume; SV, stroke volume; LVM, left ventricular mass; EF, ejection fraction.
p < 0.05.